EcoDrugPlus

Ensembl ID : ENSSVLG00005023219
Gene Symbol: -
Cross references: -
44 Possible Orthologues:

Ensembl ID : ENSSVLG00005023320
Gene Symbol: -
Cross references: -
44 Possible Orthologues:

Ensembl ID : ENSSVLG00005008214
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSSVLG00005000425
Gene Symbol: -
Cross references: -
280 Possible Orthologues:

Ensembl ID : ENSSVLG00005000640
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSSVLG00005001116
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSSVLG00005002105
Gene Symbol: -
Cross references: -
283 Possible Orthologues:

Ensembl ID : ENSSVLG00005003024
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Ensembl ID : ENSSVLG00005003084
Gene Symbol: -
Cross references: -
254 Possible Orthologues:

Ensembl ID : ENSSVLG00005003416
Gene Symbol: -
Cross references: -
420 Possible Orthologues:

Ensembl ID : ENSSVLG00005003685
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSSVLG00005003860
Gene Symbol: -
Cross references: -
217 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).